×
We couldn’t find any recent recommendations for this company (matched by symbol or BSE code). Please check back later.
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.09 | 84.8 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| DR.AGARWALS EYE HOSPITAL LTD. | NA | NA | NA | NA | 2,259 | 39.1 |
| SMS PHARMACEUTICALS LTD. | 1966.4 | 182.07 | 1960.47 | 2.05 | 2231 | 30.5 |
| NOVARTIS INDIA LTD. | NA | NA | NA | NA | 2162 | 21.0 |
Dr.Agarwals Eye Hospital Ltd., with Security Code 526783, is a leading player in the Hospital industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 63.5 | 69.2 | 77.8 | 83.3 | 75.7 | 80.7 | 100.0 | 102.2 | 95.1 | 99.8 |
| Expenses | 48.2 | 48.3 | 55.9 | 60.9 | 55.2 | 56.3 | 68.6 | 72.3 | 69.5 | 68.2 |
| Operating Profit | 15.4 | 20.9 | 21.9 | 22.4 | 20.5 | 24.4 | 31.4 | 29.9 | 25.6 | 31.6 |
| OPM % | 24.16% | 30.23% | 28.15% | 26.89% | 27.08% | 30.28% | 31.4% | 29.24% | 26.94% | 31.67% |
| Other Income | 0.2 | 0.6 | 1.1 | 2.3 | 1.0 | 2.5 | 0.4 | 2.3 | 2.3 | 0.1 |
| Interest | 1.7 | 1.8 | 1.6 | 1.7 | 1.8 | 2.0 | 3.0 | 3.7 | 3.9 | 2.9 |
| Depreciation | 7.1 | 1.5 | 5.9 | 6.3 | 6.9 | 7.5 | 9.9 | 9.4 | 10.0 | 10.2 |
| Profit before tax | 6.7 | 18.2 | 15.5 | 16.7 | 12.7 | 17.3 | 18.9 | 19.1 | 14.1 | 18.6 |
| Tax % | -24.5% | -24.8% | -25.7% | -24.4% | -25.8% | -26.2% | -25.4% | -26% | -26% | -14% |
| Net Profit | 5.1 | 13.7 | 11.5 | 12.6 | 9.4 | 12.8 | 14.1 | 14.2 | 10.4 | 16.0 |
| EPS in Rs | 10.77 | 29.11 | 24.55 | 26.79 | 20.09 | 27.21 | 30.02 | 30.11 | 22.13 | 0 |
No Consolidated data available.
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 13% |
| 3 Years: | 32% |
| TTM: | 23% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 34% |
| 5 Years: | 31% |
| 3 Years: | 226% |
| TTM: | 9% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 42% |
| 5 Years: | 81% |
| 3 Years: | 82% |
| 1 Year: | 38% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | 0% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| News Date ▲▼ | Headline ▲▼ | Issuer Entity ▲▼ | Issuer Type ▲▼ | Order Size ▲▼ | Time Period ▲▼ | |
|---|---|---|---|---|---|---|
| Loading company updates… | ||||||
We couldn’t find any filings or updates in the Company News collection for this BSE code.
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|